Gut bacteria cocktail aims to tame ulcerative colitis

NCT ID NCT07296315

First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 4 times

Summary

This study tests a new medicine called MH002, which contains live bacteria meant to restore gut health in people with mild-to-moderate ulcerative colitis. About 204 adults whose current treatment isn't working well enough will receive either a low dose, high dose, or placebo capsule daily for 12 weeks. The main goal is to see if MH002 can reduce gut inflammation and improve symptoms.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
MH002 (a live bacterial product made from 6 natural gut bacteria strains)
What this could lead to
If successful, this could provide a new treatment option for people with mild-to-moderate ulcerative colitis that is not well controlled by current medications.
What could go wrong
This is a Phase 2 trial with only 204 participants, so results are still early. The treatment may not work better than placebo, and long-term safety is not yet established.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLITIS, ULCERATIVE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • ARA Professionals

    RECRUITING

    Miami, Florida, 33155, United States

  • American Hospital Network LLC

    RECRUITING

    Tbilisi, 0102, Georgia

  • Aversi Clinic LLC

    RECRUITING

    Tbilisi, 0160, Georgia

  • Cross Creek Medical Clinic

    RECRUITING

    Fayetteville, North Carolina, 28304, United States

  • JSC Georgian Clinics

    RECRUITING

    Kutaisi, 4600, Georgia

  • K. Eristavi National Center of Experimental and Clinical Surgery JSC

    RECRUITING

    Tbilisi, 0159, Georgia

  • LEPL The First University Clinic of Tbilisi State Medical University

    RECRUITING

    Tbilisi, 0178, Georgia

  • LLC The First Medical Center

    RECRUITING

    Tbilisi, 0180, Georgia

  • LTD Institute of Clinical Cardiology

    RECRUITING

    Tbilisi, 0159, Georgia

  • LTD Krol Medical Corporation

    RECRUITING

    Tbilisi, 0180, Georgia

  • Malkhaz Katsiashvili Multiprofile Emergency Medicine Center LLC

    RECRUITING

    Tbilisi, 0180, Georgia

  • Orlando Gastroenterology, P.A.

    RECRUITING

    Orlando, Florida, 32835, United States

  • PMSI "Timofei Mosneaga" Republican Clinical Hospital

    RECRUITING

    Chisinau, MD2025, Moldova

  • Peters Medical Research

    RECRUITING

    High Point, North Carolina, 27260, United States

  • Southern Star Research Institute

    RECRUITING

    San Antonio, Texas, 78229, United States

  • Tropical Clinical Trials

    RECRUITING

    Palmetto Bay, Florida, 33176, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.